Literature DB >> 12923858

Double heterozygosity in bone growth disorders: four new observations and review.

Maureen A Flynn1, Richard M Pauli.   

Abstract

Because matings between individuals of small stature is common, information regarding double heterozygosity for dominantly inherited bone growth disorders is of considerable importance. We summarize seven occurrences of four combinations of double heterozygosity (achondroplasia/spondyloepiphyseal dysplasia congenita, achondroplasia/pseudoachondroplasia, achondroplasia/osteogenesis imperfecta type I, achondroplasia/hypochondroplasia (non-FGFR3)), and review additional reports from the literature. Each of the eight different examples of double heterozygosity for bone growth disorders now reported results in distinct phenotypic features, differing severity, and disparate expectations. We document the natural history of each. The genetic processes underlying these disorders also are examined to assess whether knowledge of molecular mechanisms can be used to predict clinical severity. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923858     DOI: 10.1002/ajmg.a.20143

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  Skeletal dysplasias.

Authors:  Deborah Krakow
Journal:  Clin Perinatol       Date:  2015-04-08       Impact factor: 3.430

2.  Novel and Recurrent Mutations in the FGFR3 Gene and Double Heterozygosity Cases in a Cohort of Brazilian Patients with Skeletal Dysplasia.

Authors:  Maria E S Gomes; Thatiane Y Kanazawa; Fernanda R Riba; Natálya G Pereira; Maria C C Zuma; Natana C Rabelo; Maria T Sanseverino; Dafne D G Horovitz; Juan C Llerena; Denise P Cavalcanti; Sayonara Gonzalez
Journal:  Mol Syndromol       Date:  2018-02-02

Review 3.  Achondroplasia: a comprehensive clinical review.

Authors:  Richard M Pauli
Journal:  Orphanet J Rare Dis       Date:  2019-01-03       Impact factor: 4.123

4.  Novel phenotype of achondroplasia due to biallelic FGFR3 pathogenic variants.

Authors:  Irene J Chang; Angela Sun; Maryse L Bouchard; Shawn E Kamps; Susan Hale; Stephen Done; Michael J Goldberg; Ian A Glass
Journal:  Am J Med Genet A       Date:  2018-07       Impact factor: 2.802

5.  FGFR3 mutation frequency in 324 cases from the International Skeletal Dysplasia Registry.

Authors:  Yuan Xue; Angela Sun; P Betty Mekikian; Jorge Martin; David L Rimoin; Ralph S Lachman; William R Wilcox
Journal:  Mol Genet Genomic Med       Date:  2014-08-05       Impact factor: 2.183

6.  Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report.

Authors:  Tadashi Nagata; Masaki Matsushita; Kenichi Mishima; Yasunari Kamiya; Kohji Kato; Miho Toyama; Tomoo Ogi; Naoki Ishiguro; Hiroshi Kitoh
Journal:  Mol Genet Genomic Med       Date:  2020-01-23       Impact factor: 2.183

7.  Apparently benign craniocervical signs in achondroplasia: "neurologic leftovers" identified through a retrospective dataset.

Authors:  Cory J Smid; Janet M Legare; Peggy Modaff; Richard M Pauli
Journal:  Orphanet J Rare Dis       Date:  2020-10-23       Impact factor: 4.123

8.  Identification of a novel COL10A1: c.1952 G>T variant in a family with Schmid metaphyseal chondrodysplasia and development of a noninvasive prenatal testing method.

Authors:  Yanchou Ye; Weihao Li; Guan Wang; Longsheng Zhan; Junwei Lin; Tian Li; Jun Zhang
Journal:  Mol Genet Genomic Med       Date:  2021-08-23       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.